Cwm LLC Has $153,000 Stake in Haleon plc (NYSE:HLN)

Cwm LLC boosted its stake in shares of Haleon plc (NYSE:HLN) by 13.1% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 18,606 shares of the company’s stock after buying an additional 2,156 shares during the quarter. Cwm LLC’s holdings in Haleon were worth $153,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. FMR LLC grew its holdings in Haleon by 22.2% during the 3rd quarter. FMR LLC now owns 53,951,936 shares of the company’s stock worth $449,420,000 after acquiring an additional 9,812,040 shares during the period. Wellington Management Group LLP bought a new stake in Haleon in the third quarter worth approximately $42,640,000. Envestnet Asset Management Inc. lifted its stake in Haleon by 121.2% in the third quarter. Envestnet Asset Management Inc. now owns 5,931,187 shares of the company’s stock valued at $49,407,000 after buying an additional 3,249,517 shares during the period. Cambiar Investors LLC bought a new position in shares of Haleon during the 4th quarter worth approximately $15,225,000. Finally, Kayne Anderson Rudnick Investment Management LLC increased its stake in shares of Haleon by 6,593.0% in the 3rd quarter. Kayne Anderson Rudnick Investment Management LLC now owns 1,692,937 shares of the company’s stock valued at $14,102,000 after acquiring an additional 1,667,643 shares in the last quarter. Institutional investors own 6.67% of the company’s stock.

Haleon Stock Performance

NYSE HLN opened at $8.30 on Monday. The company has a market cap of $37.90 billion, a P/E ratio of 27.67, a PEG ratio of 2.17 and a beta of 0.28. The company has a fifty day simple moving average of $8.33 and a 200 day simple moving average of $8.29. The company has a current ratio of 1.04, a quick ratio of 0.73 and a debt-to-equity ratio of 0.53. Haleon plc has a 12-month low of $7.70 and a 12-month high of $8.98.

Haleon Dividend Announcement

The firm also recently declared a semi-annual dividend, which will be paid on Thursday, May 16th. Investors of record on Friday, March 15th will be given a dividend of $0.1064 per share. This represents a dividend yield of 1.8%. The ex-dividend date is Thursday, March 14th. Haleon’s payout ratio is 70.00%.

Analysts Set New Price Targets

HLN has been the subject of a number of research reports. Argus restated a “buy” rating on shares of Haleon in a report on Tuesday, March 26th. HSBC began coverage on Haleon in a research report on Wednesday, April 17th. They issued a “buy” rating for the company. Two investment analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. According to MarketBeat, Haleon has an average rating of “Moderate Buy”.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.